3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
4
INDUSTRY
3
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Ovarian Neoplasms
1
Fallopian Tube Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Interventions
Paclitaxel
27
Carboplatin
23
Cisplatin
16
Topotecan
8
Taxes
8
Docetaxel
7
Gemcitabine
6
Filgrastim
5
Etoposide
4
Doxorubicin
4
Cyclophosphamide
4
Psychiatric Rehabilitation
3
Ifosfamide
3
Chemotherapy, Adjuvant
3
rubitecan
2
pegfilgrastim
2
paclitaxel poliglumex
2
liposomal doxorubicin
2
Trabectedin
2
Surgical Procedures, Operative
2
Polymerase Chain Reaction
2
Peripheral Blood Stem Cell Transplantation
2
Irinotecan
2
GEN-1
2
Fenretinide
2
Erlotinib Hydrochloride
2
Drug Therapy
2
Celecoxib
2
Bevacizumab
2
Amifostine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Ovarian Neoplasms
×
Laparotomy
×
Clear all
NCT00008138
2016-01-08
S0009
SWOG Cancer Research Network
Phase 2
Completed
62 enrolled
9 charts